Americans Drug Their Children with 300 Percent More Psychotropic Meds

Email this article to a friend

Printable Version

Articles Related to This Article: • 28 Senators vote to maintain Big Pharma monopoly over U.S. consumers; Republicans oppose free trade for medicine • Rising popularity of medical tourism reveals deterioration of U.S. healthcare system • Disease Economy: How the United States economy runs on "treating" chronic disease NaturalNews Store Specials: • Revolutionary new Hurom Slow Juicer at the lowest price on the 'net + FREE shipping! • Certified Organic Nutiva Hemp Seeds at a huge discount (+ FREE bottle of hemp oil) • Omega-3 rich Chia Seeds at under $5 / lb. See more at the NN store...

(NaturalNews) Psychotropic drugs are prescribed to children in the United States at three times the rate of children in Europe, according to one of the first studies to rigorously compare such prescription patterns between different countries.

"There is significantly greater use of atypical antipsychotics and selective serotonin reuptake inhibitor (SSRI)-type antidepressants for child mental health treatment in U.S. than in Western Europe," lead researcher Julie Zito said.

Zito and colleagues from the University of Maryland's School of Pharmacy examined the prescription of psychotropic drugs, including stimulants such as Ritalin and antidepressants such as Prozac, to more than 600,000 people under the age of 20 in the United States, Germany and the Netherlands between 1999 and 2000. They found that 6.7 percent of children in the United States, 2.9 percent of those in the Netherlands and 2 percent of those in Germany were taking at least one psychotropic drug at the time.

Among U.S. children between the ages of five and nine, the rate was more than 8 percent, or four times the European rate. The use of more than one drug at a time by U.S. children was also widespread.

Looking specifically at different classes of medications, the researchers found that U.S. children were prescribed antidepressants and stimulants at three or more times the rate of children in Europe, and antipsychotics at between 1.5 and 2.2 times the European rate.

In the United States, more than 75 percent of psychotropic drugs were prescribed to children "off-label," for uses not approved by the FDA.

The findings were published online in the journals Child and Adolescent Psychiatry and Mental Health and BioMed Central.

Zito noted that the prescription of psychotropics in the United States has probably increased in the eight years since the study's completion.

"The US trends appear to be continuing," she said.

The researchers proffered several possible explanations for the vast differences in prescription rates between the United States and Europe.

Part of the difference may be due to different diagnosis systems, with less stringent requirements in the United States for a diagnosis of mental illness in children. For example, the criteria for a U.S. diagnosis of attention deficit hyperactivity disorder (ADHD) are much easier to meet than for the equivalent European hyperkinetic disorder. Likewise, a diagnosis of childhood bipolar disorder is much more common in the United States.

Other differences in the medical establishments include a much higher per capita number of child psychiatrists in the United States (meaning there are more people to write psychotropic prescriptions) and the European public health system's aversion to prescribing expensive, patented antidepressants and antipsychotics. European doctors are also less comfortable prescribing stimulants to children; the practice was actually banned in France while the study was being conducted.

Another possible explanation is cultural: doctors and patients in the United States are much more likely to turn to pharmaceutical remedies than Europeans are.

"Direct-to-consumer drug advertising, which is common in the U.S., is also likely to account for some of the differences," the researchers wrote. "The increased use of medication in the U.S. also reflects the individualist and activist therapeutic mentality of U.S. medical culture."

Free registration is required to read the rest of this article...
Enter your email address to continue:  
Your email privacy is 100% protected by NaturalNews. We do not sell, rent or share emails.


Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • 28 Senators vote to maintain Big Pharma monopoly over U.S. consumers; Republicans oppose free trade for medicine • Rising popularity of medical tourism reveals deterioration of U.S. healthcare system • Disease Economy: How the United States economy runs on "treating" chronic disease	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/025375_United_States_research_health.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/025375_United_States_research_health.html">Americans Drug Their Children with 300 Percent More Psychotropic Meds</a>